Drug intelligence / Profile preview

Y-27632

Development stage
Preclinical
Lead developer
FUJIFILM Wako Pure Chemical
Modality
Small Molecules
Administration
Ophthalmic, Topical, Intravenous, Intraperitoneal, Intracardiac, Intrathecal
01

Overview

Y-27632 is a cell-permeable, highly potent and selective small molecule inhibitor of Rho-associated coiled-coil containing protein kinase (ROCK), specifically targeting both ROCK1 and ROCK2 isoforms by competitively binding to the ATP catalytic site. It is widely used as a biochemical tool in research to study the ROCK signaling pathway, which regulates various cellular functions including smooth muscle contraction, cytoskeletal organization, cell migration, proliferation, and apoptosis. Y-27632 has been shown to inhibit calcium sensitization leading to smooth muscle relaxation, promote survival of human embryonic stem cells and induced pluripotent stem cells during dissociation or cryopreservation, and facilitate differentiation in regenerative medicine applications. It has also been studied for its effects on corneal endothelial cells and cardiac stem cells as well as for use in tissue cryopreservation protocols.

Other names
(+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride((R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide Dihydrochloride Monohydrate
02

Targets

ROCK2 (Rho-associated coiled-coil containing protein kinase 2)ROCK1 (Rho-associated coiled-coil containing protein kinase 1)

Beyond the preview

Go deeper on Y-27632.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Y-27632.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call